NTLAIntellia Therapeutics, Inc.

$13.19

Who owns NTLA

297 institutions reported holding NTLA for 2026Q1, together 93% of the company, more than the 289 a quarter earlier.

297

Institutions reporting a position · as of 2026Q1 · up from 289 the quarter before

Shares held by institutions
110.1M

Shares held by institutions · 93% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.41B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
43%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
40
New positions
53
Positions exited
50
Added to
119
Reduced
60
Top 10 holdersof the company
57%
Institutional ownership by quarter, 2016Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q1297110.1M$1.41B
2025Q4289104.2M$938M
2025Q3278104.1M$1.80B
2025Q227699.5M$933M
2025Q1292101.3M$720M
2024Q429099.3M$1.16B
2024Q327993.2M$1.91B
2024Q228690.0M$2.02B
2024Q127991.2M$2.51B
2023Q428985.2M$2.60B
2023Q328080.1M$2.53B
2023Q228878.3M$3.19B
2023Q128578.7M$2.93B
2022Q429878.0M$2.72B
2022Q331968.0M$3.81B
2022Q229867.6M$3.44B
Largest reported holders, 2026Q1
HolderShares% of companyValue
ARK Investment Management LLC14.5M12%$186M
VANGUARD GROUP INC12.2M10%$157M
BlackRock Inc.12.2M10%$156M
STATE STREET CORP6.9M5.8%$89M
D. E. Shaw & Co., INC.5.7M4.8%$73M
TWO SIGMA INVESTMENTS, LP4.7M4.0%$60M
REGENERON PHARMACEUTICALS, INC.3.7M3.1%$47M
GEODE CAPITAL MANAGEMENT LLC2.9M2.4%$37M
UBS Group AG2.7M2.3%$34M
DIMENSIONAL FUND ADVISORS LP2.3M2.0%$30M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…